Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Aberrant expression of kallikrein-related peptidase 7 is correlated with human melanoma aggressiveness by stimulating cell migration and invasion
Show others and affiliations
2017 (English)In: Molecular Oncology, ISSN 1574-7891, E-ISSN 1878-0261, Vol. 11, no 10, p. 1330-1347Article in journal (Refereed) Published
Abstract [en]

Members of the tissue kallikrein-related peptidase (KLK) family not only regulate several important physiological functions, but aberrant expression has also been associated with various malignancies. Clinically, KLKs have been suggested as promising biomarkers for diagnosis and prognosis in many types of cancer. As of yet, expression of KLKs and their role in skin cancers are, however, poorly addressed. Malignant melanoma is an aggressive disease associated with poor prognosis. Hence, diagnostic biomarkers to monitor melanoma progression are needed. Herein, we demonstrate that although mRNA of several KLKs are aberrantly expressed in melanoma cell lines, only the KLK7 protein is highly secreted in vitro. In line with these findings, ectopic expression of KLK7 in human melanomas and its absence in benign nevi were demonstrated by immunohistochemistry in vivo. Interestingly, overexpression of KLK7 induced a significant reduction in melanoma cell proliferation and colony formation. Moreover, KLK7 overexpression triggered an increase in cell motility and invasion associated with decreased expression of E-cadherin and an upregulation of MCAM/CD146. Our results demonstrate, for the first time, that aberrant KLK7 expression leads to a switch from proliferative to invasive phenotype, suggesting a potential role of KLK7 in melanoma progression. Thus, we hypothesize that KLK7 may represent a potential biomarker for melanoma progression.

Place, publisher, year, edition, pages
2017. Vol. 11, no 10, p. 1330-1347
Keyword [en]
E-cadherin, invasion, kallikrein-related peptidase 7, melanoma, migration, proliferation
National Category
Cell and Molecular Biology
Identifiers
URN: urn:nbn:se:umu:diva-142381DOI: 10.1002/1878-0261.12103ISI: 000417440300002PubMedID: 28636767OAI: oai:DiVA.org:umu-142381DiVA, id: diva2:1161030
Available from: 2017-11-29 Created: 2017-11-29 Last updated: 2018-06-09Bibliographically approved

Open Access in DiVA

fulltext(2660 kB)9 downloads
File information
File name FULLTEXT01.pdfFile size 2660 kBChecksum SHA-512
11d77367ab0d7f258c53e1a5449b194db9f0a943cd38b994a2cf646c4228f7ce7278b7c9ab1e4190a86fff9c9bb919f45608c866baaac44b401765340b25dbf0
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Brattsand, Maria
By organisation
Pathology
In the same journal
Molecular Oncology
Cell and Molecular Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 9 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 60 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf